These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 30252437)
1. Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models. Volgin AD; Yakovlev OA; Demin KA; Alekseeva PA; Kyzar EJ; Collins C; Nichols DE; Kalueff AV ACS Chem Neurosci; 2019 Jan; 10(1):143-154. PubMed ID: 30252437 [TBL] [Abstract][Full Text] [Related]
2. Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish. Volgin AD; Yakovlev OA; Demin KA; Alekseeva PA; Kalueff AV Behav Brain Res; 2019 Feb; 359():274-280. PubMed ID: 30366034 [TBL] [Abstract][Full Text] [Related]
3. DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens. Lakstygal AM; Kolesnikova TO; Khatsko SL; Zabegalov KN; Volgin AD; Demin KA; Shevyrin VA; Wappler-Guzzetta EA; Kalueff AV ACS Chem Neurosci; 2019 May; 10(5):2144-2159. PubMed ID: 30566832 [TBL] [Abstract][Full Text] [Related]
4. Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds. Neelkantan N; Mikhaylova A; Stewart AM; Arnold R; Gjeloshi V; Kondaveeti D; Poudel MK; Kalueff AV ACS Chem Neurosci; 2013 Aug; 4(8):1137-50. PubMed ID: 23883191 [TBL] [Abstract][Full Text] [Related]
5. Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models. Kyzar EJ; Kalueff AV Zebrafish; 2016 Oct; 13(5):379-90. PubMed ID: 27002655 [TBL] [Abstract][Full Text] [Related]
6. Comparison of stimulants and hallucinogens on shuttle avoidance in rats. Davis WM; Hatoum HT Gen Pharmacol; 1987; 18(2):123-8. PubMed ID: 3569841 [TBL] [Abstract][Full Text] [Related]
7. A primate model for the study of hallucinogens. Schlemmer RF; Davis JM Pharmacol Biochem Behav; 1986 Feb; 24(2):381-92. PubMed ID: 3952128 [TBL] [Abstract][Full Text] [Related]
10. Chronic Behavioral and Neurochemical Effects of Four Novel Ilyin NP; Nabiullin AD; Kozlova AD; Kupriyanova OV; Shevyrin VA; Gloriozova T; Filimonov D; Lagunin A; Galstyan DS; Kolesnikova TO; Mor MS; Efimova EV; Poroikov V; Yenkoyan KB; de Abreu MS; Demin KA; Kalueff AV ACS Chem Neurosci; 2024 May; 15(10):2006-2017. PubMed ID: 38683969 [TBL] [Abstract][Full Text] [Related]
11. The effects of psychotomimetics and psychomotor stimulants on two schedules promoting response switching in the rat. Evenden J Psychopharmacology (Berl); 2002 Oct; 163(3-4):381-90. PubMed ID: 12373438 [TBL] [Abstract][Full Text] [Related]
12. Neurotransmitter basis of the behavioral effects of hallucinogens. Rech RH; Commissaris RL Neurosci Biobehav Rev; 1982; 6(4):521-7. PubMed ID: 6817241 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of hallucinogens and related designer drugs. Glennon RA NIDA Res Monogr; 1991; (116):25-44. PubMed ID: 1369672 [TBL] [Abstract][Full Text] [Related]
15. Chemistry and pharmacology of hallucinogens, entactogens and stimulants. Kovar KA Pharmacopsychiatry; 1998 Jul; 31 Suppl 2():69-72. PubMed ID: 9754836 [TBL] [Abstract][Full Text] [Related]
16. Early preclinical studies of discriminable sedative and hallucinogenic drug effects. Barry H; Appel JB Psychopharmacology (Berl); 2009 Apr; 203(2):193-201. PubMed ID: 18712362 [TBL] [Abstract][Full Text] [Related]
17. Unique and potent effects of acute ibogaine on zebrafish: the developing utility of novel aquatic models for hallucinogenic drug research. Cachat J; Kyzar EJ; Collins C; Gaikwad S; Green J; Roth A; El-Ounsi M; Davis A; Pham M; Landsman S; Stewart AM; Kalueff AV Behav Brain Res; 2013 Jan; 236(1):258-269. PubMed ID: 22974549 [TBL] [Abstract][Full Text] [Related]
18. Towards experimental models of delirium utilizing zebrafish. Maslov GO; Zabegalov KN; Demin KA; Kolesnikova TO; Kositsyn YM; de Abreu MS; Petersen EV; Kalueff AV Behav Brain Res; 2023 Sep; 453():114607. PubMed ID: 37524203 [TBL] [Abstract][Full Text] [Related]
19. Tools in the Design of Therapeutic Drugs for CNS Disorders: An up-to-date Review. Sahu JK; Mishra AK Curr Mol Pharmacol; 2018; 11(4):270-278. PubMed ID: 30129422 [TBL] [Abstract][Full Text] [Related]